Table 1.
Clinical and biochemical characteristics of obese cases and controls
| Characteristics | Obese | Controls |
|---|---|---|
| Age (years) | 31.5 ± 4.8 | 32.7 ± 4.7 |
| BMI (kg/m2) | 32.21 ± 5.4* | 22.24 ± 4.2 |
| WC (cm) | 96.2 ± 6.12* | 81.6 ± 4.3 |
| WHR | 0.82 ± 0.8 | 0.79 ± 0.6 |
| Sum SF | 149. 9 ± 23. 9 | 143.9 ± 21.9 |
| Body fat% | 29.9 ± 9.9 | 27.5 ± 8.4 |
| SBP (mmHg) | 135.55 ± 9.8* | 100. 3 ± 9.4 |
| DBP (mmHg) | 88.8 ± 6.9* | 65.24 ± 8.8 |
| HOMA-IR | 6.8 ± 1.2* | 2.2 ± 1.2 |
| FBG (mg/dL) | 111.4 ± 24.7* | 81. 0 ± 21.1 |
| TC (mg/dL) | 189.9 ± 36.2* | 118.9 ± 22.2 |
| TG (mg/dL) | 146.8 (120-148.8) * | 47.55 ± 10.45 |
| HDL-C (mg/dL) | 35.6 ± 4.9* | 47.77 ± 10.8 |
| LDL-C (mg/dL) | 163 (88-162)* | 165 (88-164)* |
| MPO (ng/mL ) | 86 (66 – 92)** | 22 ± 12 (20–30) |
BMI: body mass index; WC: waist circumference; WHR: waist to hip ratio; Sum SF: sum of skin folds; SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA-IR: homeostasis model assessment-insulin resistance; FBG: fasting glucose; TC: total cholesterol; TG: triglycerides; HDL -C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; MPO: myeloperoxidase;
*
p < 0.05,
**
p < 0.001.